HOME >> BIOLOGY >> NEWS
UF researchers score gene therapy advance: Animal study shows high blood pressure prevented in future generations

GAINESVILLE---A form of gene therapy to ward off high blood pressure in rats appears to permanently alter the animals' DNA blueprint, preventing their offspring from inheriting the disorder, University of Florida scientists report today (11/12) in Circulation Research: Journal of the American Heart Association.

The advance represents the first time researchers have been able to protect future generations through gene therapy for any condition, said UF molecular physiologist Mohan K. Raizada. Other studies have shown random bits of inserted genes can be passed on, but with no therapeutic effect. The new approach involves using a form of genetic brilliance to block the action of a harmful hormone, angiotensin, which causes blood vessels to narrow, increasing blood pressure.

"The neat part of this study is we're able to show both the effects on high blood pressure as well as on the organs involved in the control of blood pressure," Raizada said. "We have shown that this form of gene therapy not only prevents these animals from developing high blood pressure but also prevents a lot of other types of pathophysiological changes in the heart, the kidney and the arteries."

What's more, after studying two subsequent generations of rats - the original animals' "children" and "grandchildren" - researchers discovered the beneficial changes were passed on. Those offspring should have had high blood pressure but didn't, said UF vascular biologist

Craig H. Gelband. Raizada and Gelband, who are affiliated with UF's College of Medicine and the campuswide Genetics Institute, collaborated with Michael J. Katovich, in the university's College of Pharmacy on the study. The project was funded by the National Institutes of Health and the

American Heart Association's Florida affiliate. Findings from related research also were presented at this week's annual meeting of the American Heart Association in Atlanta.

While it may be years before the approach is teste
'"/>

Contact: Melanie Fridl Ross
ufcardiac@aol.com
352-690-7051
University of Florida
10-Nov-1999


Page: 1 2 3

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. $7.5 Million grant to Yale researchers for role of viruses in cancer
4. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
5. Joslin researchers clarify mechanisms for beta-cell formation
6. Virginia Tech researchers to release findings on Smith River Project
7. Molecular motor myosin VI moves hand over hand, researchers say
8. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
9. Emory researchers map structure of anti-cancer molecule
10. Leukemia stem cells identified by Stanford researchers
11. EURYI Award given for the first time to 25 young European researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... ... February 11, 2020 , ... The ... medical device accelerator in Port Covington, Baltimore. The newly formed company is developing ... addressed to manage increased demand for home dialysis treatments. The start-up company will ...
(Date:2/5/2020)... (PRWEB) , ... February 04, 2020 , ... ... Trademark Office (USPTO) issued the company a second patent related to proprietary liquid ... of Allowance compliments another patent from the USPTO issued on December 3, 2019. ...
(Date:1/29/2020)... (PRWEB) , ... January 29, 2020 , ... ... receptor and in vitro toxicology testing solutions, has announced a record earnings year ... upcoming weeks, INDIGO showed more than a twenty percent increase in revenue and ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... ... January 27, 2020 , ... Cerebyte, ... cloud and mobile computing, today announced the availability of neuroscience of transformational leadership ... use the latest neuroscience of leadership and change research to become great transformational ...
(Date:1/24/2020)... ... 24, 2020 , ... The impact of new medicines, procedures, ... and clinical services during the first two decades of the 21st century have ... Slone Partners celebrates its 20th anniversary this year, its evolution as a ...
(Date:1/22/2020)... ... January 20, 2020 , ... ... with WAVE Electronics, the largest independent electronics distributor in the US, to make ... Smart Home Systems with leading smart home products from a single fulfillment partner. ...
(Date:1/22/2020)... Conn. (PRWEB) , ... January 21, 2020 , ... ... (CTC) liquid biopsy from a simple blood draw, today announced the sale of the ... Health. The Rare Scope will be used in clinical cancer research. , “The RareScope ...
Breaking Biology Technology:
Cached News: